AzTrials
AzTrials

Acute Respiratory Distress SyndromePRO-KIDNEYNCT04286490

Prone Position and Renal Resistive Index

A study testing Prone position in people with Acute Respiratory Distress Syndrome and Acute Kidney Injury, run by University Hospital, Grenoble at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Patients suffering from Acute Respiratory Distress Syndrome (ARDS) with a prone position (PP) indication will benefit from measurements of renal resistive index, intra-abdominal pressure (IAP), urinary oxygen tension (uPO2) and ventilatory mechanics in supine position (baseline IAP), after 2 hours in PP at the current… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Prone position
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteFrance
Study dates
30 Jun 2020to 30 Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ARDS patients according to Berlin criteria, intubated, mechanically ventilated
  • with PaO₂/FiO₂ < 150 mmHg,
  • neuromuscular blockade
  • with an indication of PP done by the physician in charge
  • possibility to differ PP for one hour
  • patients should be hemodynamically stable since at least 4 hours

Who cannot join

  • Pregnant or breast-feeding women
  • legal protection, no social security affiliation
  • PP contra-indication
  • nasogastric tube contra-indication
  • extra corporeal membrane oxygenation
  • acute kidney injury at inclusion according to K-DIO criteria, chronic kidney disease defined as an estimated glomerualr filtration rate less than 30 ml/min/1.73m², kidney transplantation, renal artery stenosis, solitary kidney, albuminuria > 1.25 mg/ml
Show all 9Show fewer
  • cardiac arrhythmia
  • obesity
  • advanced cirrhosis

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hospital Grenoble University

    Grenoble, 38000

Other trials in France

About this study

Official title: Effect of Prone Position on Renal Resistive Index Among Patients With Acute Respiratory Distress Syndrome. The Role of Intra-abdominal Pressure

Patients suffering from Acute Respiratory Distress Syndrome (ARDS) with a prone position (PP) indication will benefit from measurements of renal resistive index, intra-abdominal pressure (IAP), urinary oxygen tension (uPO2) and ventilatory mechanics in supine position (baseline IAP), after 2 hours in PP at the current IAP value, thirty minutes after patients' abdomen suspension in order to resume baseline IAP and after patients' are turned back to supine position.

Being tested
Prone position
Medical subject headings
Respiratory Distress Syndrome, Acute Kidney Injury, Intra-Abdominal Hypertension

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Prone positionOther

    Abdomen suspension in prone position

Study groups in NCT04286490
Study groupRoleWhat they receive
Prone positionExperimentalNot described
Receives: Other: Prone position

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. change in renal resistive index (RRI)

    RRI measurement will be performed on a right kidney arcuate/interlobar artery, with a high frequency Doppler probe. Three to five consecutive measures will be obtained then RRI computed according to the formula: (peak systolic velocity - end diastolic velocity)/peak systolic velocity).

    Measured: At inclusion (in supine position), two hours after prone positioning, 30-minutes after the abdomen suspension maneuver

Secondary outcomes (13)
  1. change in renal medullary oxygen tension

    urinary oxygen tension (uPO₂) will be measured via a fiber-optic luminescence optode inserted through the bladder catheter lumen

    Measured: At inclusion (in supine position), two hours after prone positioning, 30-minutes after the abdomen suspension maneuver

  2. ventilatory mechanics: transpulmonary pressure

    transpulmonary pressure will be measured at the end of inspiration and expiration and continuously recorded on a datalogger

    Measured: At inclusion (in supine position), two hours after prone positioning, 30-minutes after the abdomen suspension maneuver

  3. ventilatory mechanics: driving pressure

    driving pressure will be measured at the end of inspiration and expiration and continuously recorded on a datalogger

    Measured: At inclusion (in supine position), two hours after prone positioning, 30-minutes after the abdomen suspension maneuver

  4. ventilatory mechanics: elastance

    elastance will be measured at the end of inspiration and expiration and continuously recorded on a datalogger

    Measured: At inclusion (in supine position), two hours after prone positioning, 30-minutes after the abdomen suspension maneuver

  5. haematosis

    arterial oxygen tension (PaO2) and arterial dioxide carbon tension (PaC02)

    Measured: At inclusion (in supine position), two hours after prone positioning, 30-minutes after the abdomen suspension maneuver

  6. Intra abdominal pressure

    Intra abdominal pressure will be measured thanks to a dedicated nasogastric tube with two balloons (gastric pressure)

    Measured: At inclusion (in supine position), two hours after prone positioning, 30-minutes after the abdomen suspension maneuver and two hours after patients are back in supine position

  7. Persisting effect of IAP increase in prone position when patients are back in supine position on renal resistive index

    RRI measurement will be performed on a right kidney arcuate/interlobar artery, with a high frequency Doppler probe. Three to five consecutive measures will be obtained then RRI computed according to the formula: (peak systolic velocity - end diastolic velocity)/peak systolic velocity).

    Measured: Two hours after patients are back in supine position

  8. Persisting effect of IAP increase in prone position when patients are back in supine position on urinary PO2

    urinary oxygen tension (uPO₂) will be measured via a fiber-optic luminescence optode inserted through the bladder catheter lumen

    Measured: Two hours after patients are back in supine position

  9. Persisting effect of IAP increase in prone position when patients are back in supine position on ventilatory mechanics: transpulmonary pressure

    transpulmonary pressure will be measured at the end of inspiration and expiration and continuously recorded on a datalogger

    Measured: Two hours after patients are back in supine position

  10. Persisting effect of IAP increase in prone position when patients are back in supine position on ventilatory mechanics: driving pressure

    driving pressure will be measured at the end of inspiration and expiration and continuously recorded on a datalogger

    Measured: Two hours after patients are back in supine position

  11. Persisting effect of IAP increase in prone position when patients are back in supine position on ventilatory mechanics: elastance

    elastance will be measured at the end of inspiration and expiration and continuously recorded on a datalogger

    Measured: Two hours after patients are back in supine position

  12. Persisting effect of IAP increase in prone position when patients are back in supine position on haematosis

    arterial oxygen tension (PaO2) and arterial dioxide carbon tension (PaC02)

    Measured: Two hours after patients are back in supine position

  13. Acute kidney injury

    According to creatinine or diuresis criteria of Kidney Disease: Improving Global Outcomes (K-DIGO) classification

    Measured: within 48 hours following prone position

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Feb 2020
  2. Study start30 Jun 2020
  3. Primary completion30 Jun 2022
  4. Study completion30 Jun 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04286490
Sponsor's protocol ID
38RC19.265
Acronym
PRO-KIDNEY
Status last verified
Jan 2025
First submitted
18 Feb 2020
Last updated
29 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Prone position in people with Acute Respiratory Distress Syndrome and Acute Kidney Injury, run by University Hospital, Grenoble at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

change in renal resistive index (RRI) (time frame: At inclusion (in supine position), two hours after prone positioning, 30-minutes after the abdomen suspension maneuver). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jan 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in